Cumulative rank probabilities (in parenthesis) and the surface under cumulative ranking curve (SUCRA)
| Rank | Placebo | Sitagliptin+sulfonylurea | Sitagliptin+exenatide | Linagliptin+sulfonylurea | Saxagliptin+sulfonylurea | Vildagliptin+sulfonylurea | Sitagliptin+pioglitazone | NPH+sulfonylurea |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.000 (0.000) | 0.190 (0.190) | 0.010 (0.010) | 0.105 (0.105) | 0.059 (0.059) | 0.480 (0.480) | 0.098 (0.098) | 0.058 (0.098) |
| 2 | 0.000 (0.000) | 0.365 (0.555) | 0.028 (0.037) | 0.111 (0.216) | 0.076 (0.135) | 0.257 (0.737) | 0.118 (0.216) | 0.046 (0.216) |
| 3 | 0.004 (0.004) | 0.210 (0.764) | 0.041 (0.078) | 0.233 (0.449) | 0.121 (0.256) | 0.126 (0.863) | 0.208 (0.424) | 0.058 (0.424) |
| 4 | 0.015 (0.019) | 0.126 (0.890) | 0.064 (0.142) | 0.241 (0.689) | 0.180 (0.436) | 0.071 (0.934) | 0.221 (0.646) | 0.082 (0.646) |
| 5 | 0.061 (0.080) | 0.064 (0.954) | 0.120 (0.262) | 0.149 (0.838) | 0.286 (0.722) | 0.036 (0.970) | 0.170 (0.816) | 0.116 (0.816) |
| 6 | 0.185 (0.264) | 0.029 (0.983) | 0.289 (0.551) | 0.075 (0.912) | 0.133 (0.854) | 0.017 (0.987) | 0.086 (0.901) | 0.187 (0.901) |
| 7 | 0.287 (0.551) | 0.013 (0.996) | 0.337 (0.888) | 0.050 (0.962) | 0.083 (0.938) | 0.010 (0.996) | 0.058 (0.958) | 0.164 (0.958) |
| 8 | 0.449 (1.000) | 0.004 (1.000) | 0.112 (1.000) | 0.038 (1.000) | 0.063 (1.000) | 0.004 (1.000) | 0.042 (1.000) | 0.289 (1.000) |
| SUCRA | 13.12% | 76.16% | 28.12% | 59.59% | 48.54% | 85.24% | 57.99% | 31.22% |